The Clinigen Group plc Board is committed to a sustainable and progressive dividend policy and expects interim and final dividend payments to be split approximately one-third to two-thirds respectively.
The Board has increased the interim dividend by 10% to 2.15p per share (2018: 1.95p).
The interim dividend will be paid on 17 April 2020 to shareholders on the register on 20 March 2020.
Other financial highlights include:
Gross profit up 35% (+9% on an organic basis) to £108.1m (2018: £80.0m)
Adjusted EBITDA up 42% (+10% on an organic basis) to £62.1m (2018 restated: £43.7m)
Adjusted EPS up 34% to 30.8p (2018 restated: 23.0p)
Net debt as at 31 December 2019 of £322.3m, (£305.4m excl. IFRS 16 adjustment) representing pro forma leverage of 2.4x with target leverage of 1.0x - 2.0x expected in FY21
